Skip to main content

Megna Michael R's Form 4 filing

Kiniksa Pharmaceuticals International, plc (KNSA) · filed Oct 22, 2025

Accession no.
0001464583-25-000005
Filed
Oct 22, 2025
Trade date
Oct 20, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 7 non-derivative transactions and 5 derivative transactions. Open-market sales total $1.96M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Megna Michael RCIK 0001464583Officer (CHIEF ACCOUNTING OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 20, 2025Class A Ordinary ShareMOption exerciseAcquired+791$15.50+$12,260.538,892Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseAcquired+6,195$12.97+$80,349.1545,087Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseAcquired+9,831$11.10+$109,124.154,918Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseAcquired+9,831$11.97+$117,677.0764,749Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseAcquired+12,787$10.76+$137,588.1277,536Direct
Oct 20, 2025Class A Ordinary ShareSSaleDisposed−37,255$38.72−$1,442,513.640,281Direct
Oct 20, 2025Class A Ordinary ShareSSaleDisposed−13,235$39.31−$520,267.8527,046Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 20, 2025Class A Ordinary ShareMOption exerciseDisposed−791$0.00$00Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseDisposed−6,195$0.00$00Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseDisposed−9,831$0.00$00Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseDisposed−9,831$0.00$00Direct
Oct 20, 2025Class A Ordinary ShareMOption exerciseDisposed−12,787$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)